InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,253.52
(
0.25%
)
Post# of 113882
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

rado

Send PM Follow Ignore
Followers 5
Posts 468
Boards Moderated 0
Alias Born 05/03/2005

rado

Re: rado post# 65622

Thursday, 02/27/2020 8:56:06 PM

Thursday, February 27, 2020 8:56:06 PM

Post# of 113882
ZYXI (13.30 +11% in after hours) had another great quarter. 52% revenue growth yoy, 30% increase in EBITDA yoy. Full year revenue estimate is approximately 65% to 76% above 2019 revenue. The blood volume monitor was FDA approved last year. Hired 40 reps since the beginning of the year.

http://zynexmed.investorroom.com/2020-02-27-Zynex-Announces-2019-Fourth-Quarter-and-Full-Year-Earnings
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up